ENOV
Enovis CorpNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.23B
P/E Ratio
—
EPS
$-19.89
Beta
1.49
52W High
$36.82
52W Low
$20.55
50-Day MA
$24.07
200-Day MA
$26.60
Dividend Yield
—
Profit Margin
-49.90%
Forward P/E
5.72
PEG Ratio
1.90
About Enovis Corp
Enovis Corporation is a global medical technology company. The company is headquartered in Wilmington, Delaware.
Fundamentals
| Revenue (TTM) | $2.28B |
| Gross Profit (TTM) | $1.39B |
| EBITDA | $372.25M |
| Operating Margin | 3.64% |
| Return on Equity | -55.30% |
| Return on Assets | 1.09% |
| Revenue/Share (TTM) | $39.83 |
| Book Value | $25.66 |
| Price-to-Book | 0.82 |
| Price-to-Sales (TTM) | 0.54 |
| EV/Revenue | 1.138 |
| EV/EBITDA | 22.42 |
| Quarterly Earnings Growth (YoY) | 153.10% |
| Quarterly Revenue Growth (YoY) | 5.40% |
| Shares Outstanding | $57.56M |
| Float | $56.59M |
| % Insiders | 1.62% |
| % Institutions | 119.67% |
Historical Volatility
HV 10-Day
69.88%
HV 20-Day
65.36%
HV 30-Day
67.44%
HV 60-Day
62.75%
HV Rank
91.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($43.00 target)
2
Strong Buy9
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026